Ketan Parekh Vs. Securities and Exchange Board of India

Decided On : Jul-14-2006

Court : SEBI Securities and Exchange Board of India or Securities Appellate Tribunal SAT

LAW: Regulation 11, Section 11 and 11B, Regulation 11, Section 11B, Section 11(4)(b, Regulation 11

CARDINAL: 1, 2 to 10, 2, two, two, II, three, 6.10.1999, 16.10.1999, three, two, 4(a, three, four, 1.6.1999, four, 4(a, 4(a, three, three, 12.3.2003, three, three, three, four, 4.9, two, 14.10.1999, three, 4(a, 4(a, three, three, three, three, 12.3.2003, three, three, one, one, two, three, three, three, three, three, three, three, three, four, 560/-and, 1234.55, 210.75, 585/-, 599.95, 3060, 5005, 890, three, six, 10,000/-shares, 250, 260, three, 5/-, 4.3, 241/-, 241/-, 260/-, three, 4.9, 14.10.1999, 10.03.34, 411, 15.12.51, 412.80, 40000, 412.80, 25000, 382.25, 382.25, more than 100, 382.25, 4.14, one, three, 4.14, 39, only four, 8, 27, 4(a, two, 6, 4(a, two, two, two, one, 11B, 28, two, one, two, one, one, 20, 9,99,750, 70/-, 10, 69/-, one, one, one, three, one, 24, only one, two, two, one, two, two, two

ORG: 9 Appeals, the Securities and Exchange Board of India, Board, Classic Credit Ltd., Panther Fincap &, Management Services Ltd., Luminant Investment Ltd., Chitrakut Computers Pvt. Ltd., Saimangal Investrade Ltd., Classic Infin &amp, Panther Investrade Ltd., the Board to, Ketan Parekh, Board, Lupin Laboratories Limited, Ketan Parekh, Classic Credit Limited, Panther Fincap, Management Services Limited, Saimangal Investrade Limited, Board, the Bombay Stock Exchange, BSE, National Stock Exchange, Ketan Parekh, the Securities and Exchange Board of India (Prohibition of Fraudulent and Unfair Trade Practices, the Securities and Exchange Board, Board, Board, Board, Board, Board, Ketan Parekh, Ketan Parekh, Board, the Board of Classic, the Board of the, Ketan Parekh, him.4, Board, Board, Ranbaxy, Glaxo, Cipla, Board, Board, Board, BSE, Ketan Parekh, N.H. Securities, BSE, Board, Ketan Parekh, Board, Ketan Parekh, us.5, the Board of Classic, Boards of Directors, Board, Ranbaxy, Glaxo, Cipla, Board, Board, Board, Board, Board, Lupin, Regulation, Board, Board, Board, Ketan Parekh, Board, Ketan Parekh, Board, Board, Ranbaxy, Glaxo, Cipla, BSE, Board, Regulations, Ketan Parekh, Ketan Parekh, Ketan Parekh, the Board of Directors, the Board of a company, Ketan Parekh, Board, the Show Cause Notice, CC No, the Hon'ble Supreme Court, Ketan Parekh, Board, Board, Triumph Securities Ltd., Ketan Parekh, Board, Ketan Parekh, Ketan Parekh, Nimesh Dedhia, Board, Ketan Parekh, the Board of Directors, Ketan Parekh, Board, Ketan Parekh, Ketan Parekh, Board, tandem, Ranbaxy, Glaxo, Cipla, Board, Orchid Chemicals, Board, Shri N.H. Seervai, BSE, Sensex, 01/01/1999, Nifty, 01/01/1999, Ketan Parekh, 06/10/1999, 06/10/1999, LTP, the Time Qty, Rate Traded Change, BSE Securities, BSE, BSE Securities, BSE Securities, BSE, 06/10/1999, Board, BSE, LTP, the Time Qty, BSE, BSE Shah, BSE, Board, Board, Classic Credit Ltd., Classic Credit Ltd., Lupin Laboratories Ltd., Ketan Parekh, Board, Board, Regulation 4, Board, Nirmal Bang Securities Pvt. Ltd., SAT, Shri Rafique Dada, Board, Board, Board, Board, Board, Board, Board, Board, Credit Suisse First Boston, Securities Pvt. Ltd., Desdner Klienwort Bensons Securities, CSFB, Luminant Investment Private Limited (, Ketan Parekh / Kartik Parekh, NH Securities Limited, Classic Shares and Stock Brokers Limited, Chitrakut Computers Private Limited, Classic Infin Limited, Panther Investrade Limited, Board, Ketan Parekh, Kartik Parekh, Ketan Parekh or, CSFB, Board, the Board on March 14, 2003, Kolkatta Police, Ketan Parekh, Board, Ketan Parekh and, Board, Ketan Parekh, Board, Ketan Parekh and, Boards of Directors, Board, Ketan Parekh / Kartik Parekh, Ketan Parekh, Ketan Parekh, Courts, Courts, the apex Court, Delhi Development Authority v. Skipper Construction Company Pvt, Lordships, Court, Board, Oxford, Board, Board, the Bombay Stock Exchange, BSE, the National Stock Exchange, Ketan Parekh, Ketan Parekh, Global Trust Bank, GTB, Ketan Parekh Group, CSFB Prop A/c, CSFB Sec, CSFB Sec, GTB, CSFB, GTB, CSFB, CSFB, Ketan Parekh, CSFB, Ketan Parekh, Ketan Parekh, Ketan Parekh, CSFB, CSFB, CSFB, CSFB, Ketan Parekh, CSFB, CSFB, CSFB, Ketan Parekh, Ketan Parekh, CSFB, CSFB, Ketan Parekh, CSFB, Ketan Parekh, Ketan Parekh, CSFB, Board, NSE, BSE, CSFB, Ketan Parekh, Ketan Parekh, Ketan Parekh, Board, DSQ Bio, Ketan Parekh, Board, CSFB, Ketan Parekh, Shri N.H. Seervai, Board, Ketan Parekh, Board, Ketan Parekh, Ketan Parekh, Board, Ketan Parekh, Ketan Parekh, Board, Board, the Calcutta Police, Ketan Parekh, Ketan Parekh, Board, Ketan Parekh, Board, Ketan Parekh, Board, Ketan Parekh, Board, CSFB, Board, CSFB, Board, Board, Board, Board

DATE: 2004, 12.12.2003, 14 years, September to December, 1999, March 27, 2002, 1995, 1992, 16.12.2002, 14.3.2003, April 30, 2003, June 23, 2003, the day to day, 14.10.1999, September to December 1999, the previous day's, 14.3.2003, the day to day, the previous day's, April 1999 to December 1999, January 2000, September to December 1999, the day to day, 14.3.2003, 30th July 2002, the 24th of the March 2003, the first week of April, 2003, March 2003, the day, 1480, 30/12/1999, 14/10/1999, 10000, 10000, 372010161, 10000, 372010162, 10000, 372010166, 10000, 260.1, 10000, 372010169, last three, the previous day's, that day, 10.03.34 25000, 25000, 460120041, the previous day's, the previous day, 14.10.1999, the previous day, 14.10.1999, 14.10.1999, that day, the previous day's, 2003, September, 1999 to, 1999, March 27, 2002, July 30, mid February to mid March, 2001, April 1, 2000 to March 31, 2001, June 19, 2003, December 12, 2003, 14 years, the day, the day, the second working day, two working days, the day, 2000-01, June 30, 2001, Monday to Friday, Wednesday to Tuesday, July, 2001, Monday, Monday, October 30, 2000, a few days, the day, the day, the days, April 1, 2000 to March 31, 2001, their day to day, their day to day, a period of, 18 months, two years, 14 years

PERSON: Ketan V. Parekh, Karthik K. Parekh, Lupin, Panther, Saimangal, Lupin, Panther, Saimangal, Lupin, Lupin, Lupin, Lupin, Lupin, Panther, Saimangal, Panther, Saimangal, Panther, Lupin, Panther, Saimangal, Lupin, Lupin, Novartis, Lupin, Lupin, Panther, Saimangal, Lupin, Lupin, Lupin, Lupin, Panther, Saimangal, Shri Ketan Parekh, Kartik Parekh, Ketan Parekh, Lupin, Lupin, Lupin, Ketan Parekh, Panther, Saimangal, Panther, Saimangal, Lupin, Lupin, Lupin, Lupin, Lupin, Novartis, Lupin, Lupin, Lupin, Lupin, Lupin, Lupin, Lupin, Shri Seervai, Regulations, Lupin, Shri Rafiq Dada, Panther, Saimangal, Ketan Parekh, Panther, Saimangal, Shri Rafiq Dada, Lupin, Lupin, Novartis, Lupin, Shri Rafiq Dada, Lupin, Panther, Saimangal, Enquiry, Ketan V. Parekh, Ketan Parekh, Ketan V. Parekh, Ketan Parekh, Panther, Saimangal, Dedhiya, Kartik Parekh, Shri N.H.Seervai, Panther, Saimangal, Lupin, Shri Ketan Parekh, Lupin, Lupin, Novartis, Lupin, Lupin, Arbindo Pharma, Ipca Lab, Nicholas Piramal, Pharma, Torrent Pharma, Lupin, 01/09/1999, Torrent Pharma, 01/09/1999, Lupin, Lupin, Lupin, Lupin, Lupin, Lupin, Lupin, Buyer andBuyer, Buyer andBuyer, Lupin, C.J. Dalal, Praveen V. Shah, Lupin, Lupin, Lupin, Lupin, Lupin, Lupin, Lupin, Lupin, Lupin, Lupin, Lupin, L.J., Rafique Dada, Lupin, Lupin, Panther, Kartik Parekh, Panther, Panther, Kartik Parekh, Ketan V. Parekh, Ketan Parekh, Kartik Parekh, Kartik Parekh, Kartik Parekh, Parekh, Tejwant Singh, Tejwant Singh, Tejwant Singh, Ketan Parekh, Panther, Panther, Panther, Panther, Panther, Panther, Panther, Panther, Panther, Panther, Panther, Panther, Panther, Panther, Ketan Parekh, Shri Ketan Parekh, Shri Ketan Parekh, Shri Ketan Parekh, Ketan Parekh, Shri Ketan Parekh

GPE: KP, Kolkata, Saimangal, KP, Kolkata, Mahendra, India, Saimangal, KP, KP, KP, KP, KP, KP, KP, England, the United States, KP, KP, KP, India, KP, KP, KP, KP, KP, Panther, Panther, KP, KP, KP, KP, KP, KP, KP, KP

NORP: well.3

PRODUCT: Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Comp, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, Classic, well.23

ORDINAL: first, first, first, first, first, first, first, second, second, first, first, first, first, first, second, first, first, second

PERCENT: less than 18%, 82.4%, 121.19%, about 185%, 8%, 8%, 50%, 25%, less than 25%

FAC: Shri N.H. Seervai

WORK_OF_ART: Nimesh Dedhia

LOC: Arbindo Pharma

TIME: less than four minutes, 10.14.37 hours, 10.03.34 hours, 9.55 a.m., Between 9.55 a.m. and 10.03.34 hours, 10.03.34 hours, less than 5 minutes, 14:02:41 hours to, 14:07:13 hours, less than seven minutes, a few minutes

MONEY: 250 245 56/10/99, 260 255 56/10/99, 260.25, 0.05